Abstract:Organismal aging has been associated with diverse metabolic and functional changes across tissues. Within the immune system, key features of physiological hematopoietic cell aging include increased fat deposition in the bone marrow, impaired hematopoietic stem and progenitor cell (HSPC) function, and a propensity towards myeloid differentiation. This shift in lineage bias can lead to pre-malignant bone marrow conditions such as clonal hematopoiesis of indeterminate potential (CHIP) or clonal cytopenias of undetermined significance (CCUS), frequently setting the stage for subsequent development of age-related cancers in myeloid or lymphoid lineages. At the systemic as well as sub-cellular level, human aging has also been associated with diverse lipid alterations, such as decreased phospholipid membrane fluidity that arises as a result of increased saturated fatty acid (FA) accumulation and a decay in n-3 polyunsaturated fatty acid (PUFA) species by the age of 80 years, however the extent to which impaired FA metabolism contributes to hematopoietic aging is less clear. Here, we performed comprehensive multi-omics analyses and uncovered a role for a key PUFA biosynthesis gene, , in mouse and human immune cell aging. Whole transcriptome RNA-sequencing studies of bone marrow from aged mutant (enzyme-deficient) mice compared with age-matched controls revealed global down-regulation in lymphoid cell markers and expression of genes involved specifically in B cell development. Flow cytometric analyses of immune cell markers confirmed an aging-associated loss of B cell markers that was exacerbated in the bone marrow of mutant mice and unveiled CD79B, a vital molecular regulator of lymphoid progenitor development from the pro-B to pre-B cell stage, as a putative surface biomarker of accelerated immune aging. Complementary lipidomic studies extended these findings to reveal select alterations in lipid species in aged and mutant mouse bone marrow samples, suggesting significant changes in the biophysical properties of cellular membranes. Furthermore, single cell RNA-seq analysis of human HSPCs across the spectrum of human development and aging uncovered a rare subpopulation (<7%) of CD34+ HSPCs that expresses in healthy adult bone marrow. This HSPC subset, along with -expressing lymphoid-committed cells, were almost completely absent in CD34+ cells isolated from elderly (>60 years old) bone marrow samples. Together, these findings uncover new roles for lipid metabolism enzymes in the molecular regulation of cellular aging and immune cell function in mouse and human hematopoiesis. In addition, because systemic loss of ELOVL2 enzymatic activity resulted in down-regulation of B cell genes that are also associated with lymphoproliferative neoplasms, this study sheds light on an intriguing metabolic pathway that could be leveraged in future studies as a novel therapeutic modality to target blood cancers or other age-related conditions involving the B cell lineage.

RNA Modifications Shape Hematopoietic Stem Cell Aging: Beyond the Code

Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells

Molecular and cellular mechanisms of aging in hematopoietic stem cells and their niches

Single-cell RNA-seq reveals a concomitant delay in differentiation and cell cycle of aged hematopoietic stem cells

RNA modifications in aging-associated cardiovascular diseases

Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets

Epitranscriptomics: new players in an old game.

Integrated Single-Cell Bioinformatics Analysis Reveals Intrinsic and Extrinsic Biological Characteristics of Hematopoietic Stem Cell Aging

Aging through an epitranscriptomic lens

Regulation and roles of RNA modifications in aging‐related diseases

Age-related Noncanonical TRMT6–TRMT61A Signaling Impairs Hematopoietic Stem Cells

Deciphering the evolving niche interactome of human hematopoietic stem cells from ontogeny to aging

Single Cell Transcriptomics to Understand HSC Heterogeneity and Its Evolution upon Aging

Dysregulated RNA processing and metabolism: a new hallmark of ageing and provocation for cellular senescence

Global transcriptomic profiling of the bone marrow stromal microenvironment during postnatal development, aging and inflammation

Increasing Complexity of Molecular Landscapes in Human Hematopoietic Stem and Progenitor Cells during Development and Aging

An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state

Orchestration of alternative splicing regulates bone marrow mesenchymal stem cells fate during aging

Systemic deficits in lipid homeostasis promote aging-associated impairments in B cell progenitor development

Meta-analysis of the transcriptome identifies aberrant RNA processing as common feature of aging in multiple species

Insights into the epitranscriptomic role of N6-methyladenosine on aging skeletal muscle